Angusta 25 ug
Angusta 25 ug is a medicine authorised by Swissmedic under authorisation number 67580. The authorisation holder is Norgine AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 January 2022 and the authorisation is valid without a time limit. ATC code G02AD06 places the medicine in the group Other gynecologicals.
| Authorisation number | 67580 |
|---|---|
| Name | Angusta 25 ug |
| Full name | Angusta 25 ug, Tabletten |
| Authorisation holder | Norgine AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G02AD06 |
| First authorisation | 10 January 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Angusta 25 ug, Tabletten | B | 10 January 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 8 | Tablette(n) | G02AD06 | 09.01.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Angusta 25 ug authorised in Switzerland?
Yes. Angusta 25 ug is authorised by Swissmedic under authorisation number 67580, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Angusta 25 ug have?
Angusta 25 ug is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Angusta 25 ug?
The authorisation holder is Norgine AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.